Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis

Br J Dermatol. 2018 Jul;179(1):101-109. doi: 10.1111/bjd.16137. Epub 2018 Apr 14.

Abstract

Background: Psoriasis exhibits several extracutaneous manifestations. Little is known about hepatic parameters specifically associated with psoriasis.

Objectives: To study whether psoriasiform dermatitis is associated with liver injury.

Methods: We studied liver parameters of inflammation and fibrosis in a murine model of psoriasiform dermatitis induced by topical application of imiquimod for 9 weeks.

Results: Topical treatment with imiquimod induced a form of psoriasiform dermatitis reminiscent of the human disorder, characterized by thickened and scaly skin, psoriasiform epidermal hyperplasia, altered keratinocyte differentiation and cutaneous overexpression of interleukin-17A. Mice with dermatitis displayed hepatitis, as shown by elevation of plasma transaminase levels, as well as portal and periportal hepatitis, characterized by T-lymphocyte (CD3ε+ ) and polymorphonuclear cell (Gr1+ ) infiltrates. The hepatitis progressed towards liver fibrogenesis, as shown by excessive Sirius red staining, which is consistent with the expression of α-smooth muscle actin by hepatic stellate cells.

Conclusions: These results indicate that liver inflammation and fibrosis are associated with experimental psoriasiform dermatitis. Our results suggest that psoriatic inflammation may be associated with specific liver injury.

MeSH terms

  • Animals
  • Chemical and Drug Induced Liver Injury / etiology
  • Disease Models, Animal
  • Drug Eruptions / etiology*
  • Imiquimod / administration & dosage
  • Imiquimod / toxicity*
  • Interferon Inducers / toxicity*
  • Liver Cirrhosis / etiology*
  • Male
  • Mice, Inbred C57BL
  • Psoriasis / complications*

Substances

  • Interferon Inducers
  • Imiquimod